VelaSmooth™ Therapy – FDA Gives Approval for Cellulite Treatment

By wd-admin June 16, 2005 No Comments

Austin, TX – June 16, 2005 – Syneron Medical Ltd. announced earlier this week the US Food & Drug Administration (FDA) 510(k) pre-marketing clearance of the VelaSmooth™ medical device for the temporary reduction in the appearance of cellulite.  VelaSmooth™ offers a non-surgical, no downtime alternative for patients wishing to treat the appearance of cellulite.

The innovative VelaSmooth™ treatment combines radiofrequency waves, a laser, and a mechanical massage to break up the fat and mobilize the water from tissues to safely and effectively re-contour the skin’s surface, specifically where problem areas of cellulite occur. In addition to the 510(k) clearance, the FDA created a new product category for VelaSmooth™.  According to Dr. Amir Waldman, head of Clinical and Regulatory Affairs for Syneron, this designation of a new product category “reaffirms how technically innovative this device is for the treatment of cellulite.”

Dr. Gregory Nikolaidis, founder of Westlake Dermatology & Cosmetic Surgery, was one of the first physicians in the United States offering VelaSmooth™ treatments to patients.  Since November, approximately 500 treatments have been performed at the practice.  Dr. Nikolaidis often combines VelaSmooth™ treatments with mesotherapy for even more dramatic results.

Dr. Nikolaidis’ experience and expertise is sought by laser companies like Syneron, and he is currently featured on the Syneron website (www.syneron.com).



Comments are closed.